SCOTTSDALE, AZ--(MARKET WIRE)--Aug 1, 2007 -- Medistem Laboratories, Inc. (OTC BB:MDSM.OB - News) (Frankfurt:S2U.F - News) announced today the filing of IP and publication of a peer reviewed paper describing a novel method of selecting specific subsets of autistic patients for treatment with a combination of cellular therapies.
